What is Seaport Therapeutics 's financing cash flow?

Seaport Therapeutics (SPTX) reported financing cash flow of -$783K in Q1 2026.

What does financing cash flow mean?

Total net cash provided by or used in financing activities — debt issuance/repayment, equity transactions, and dividend payments.

Seaport Therapeutics SPTX Financing Cash Flow

Financing Cash Flow at other companies

MYR GroupMYRG

-$56.35M+13.3%

SSR MiningSSRM

-$78.22M-3,024%

NNN REITNNN

-$81.09M-1,056%

Piper SandlerPIPR

-$168.92M-21.0%

RepligenRGEN

-$5.54M-10.2%

Radian GroupRDN

-$55.41M+70.4%

Other financials

Income statement

See full

Operating income-$27.5M-70.2%

Net income-$25.4M-93.6%

EPS (diluted)-$10.34-83.0%

Balance sheet

See full

Cash & equivalents$52.9M—

Total debt$5.3M—

Total equity-$115.6M-220%

Total assets$227.7M—

Cash flow

See full

Operating cash flow-$20.2M+0.2%

CapEx--100%

Free cash flow-$20.2M+0.4%

Valuation

See full

Market cap$972.65M—

Enterprise value$925.08M—

Returns & leverage

See full

Debt / equity-0×—

Current ratio13.2×—

Where this comes from

Reported directly by Seaport Therapeutics in its filing.

Tagged under the XBRL concept us-gaap:NetCashProvidedByUsedInFinancingActivities.

The official record: Seaport Therapeutics ’s 10-Q, filed June 8, 2026, on SEC EDGAR. View the filing →

Ask your AI about Seaport Therapeutics 's financing cash flow.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Seaport Therapeutics 's financing cash flow?: Seaport Therapeutics (SPTX) reported financing cash flow of -$783K in Q1 2026.
What does financing cash flow mean?: Total net cash provided by or used in financing activities — debt issuance/repayment, equity transactions, and dividend payments.